Gadobenate Dimeglumine injection
Product Description
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Categories
Jiangsu Hengrui Medicine Co., Ltd.
-
CN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
More Products from Jiangsu Hengrui Medicine Co., Ltd. (99)
-
Product Tegafur, Gimeracil, Oteracil Potassium Capsules
It is used for the treatment of advanced gastric cancer.
Strength:
Tegafur: 20mg, Gimeracil: 5.8mg, Oteracil potassium: 19.6mg;
Tegafur: 25mg, Gimeracil: 7.25mg, Oteracil potassium: 24.5mg
It has been approved by NMPA.
-
Product Temozolomide for Injection
It is an oral chemotherapy drug. It is analkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.
Strength: 100mg
It has been approved by CFDA.
-
Product Zoledronic Acid for Injection
It is a bisphosphonate drug given intravenously to treat some bone diseases. It is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis.... -
Product Bupivacaine Liposome Injectable Suspension
It is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, andepidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action.
Strength: 133mg/10ml... -
Product Eribulin Mesylate Injection
Eribulin Mesylate Injection is used to treat certain patients with breast cancer and liposarcoma.
Strength: 1mg/2ml
This product is still in R & D stage.
-
Product Gadobutrol Injection
Gadobutrol Injection is a gadolinium-based MRI contrast agent (GBCA).
Strength: (604.72mg/ml) *2ml *7.5ml *10ml *15ml *30ml *65ml
This product is still in R & D stage.
-
Product Iohexol Injection
Iohexol is a kind of contrast media.
Strength: to be determined.
This product is still in R&D stage.
-
Product Ioversol Injection
Ioversol is an organoiodine compound that used as a contrast medium. It features both a high iodine content, as well as several hydrophilic groups.
Strength: 320mg I/ml (50ml; 100ml)
Dossiers are in preparation for US-FDA approval.
-
Product Azilsartan tablets
Azilsartan is an angiotensin II receptor antagonist indicated for the treatment of mild to moderate essential hypertension. Strength: 20mg, 40mg
Standard: In-house -
Product Butorphanol Tartrate Injection
It is a kind of analgesics.
Strength: 4mg/2ml, 1mg/1ml
Standard: In-house -
Product Dutasteride capsules
Dutasteride is a triple 5α-reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone. It is used to treat benign prostatic hyperplasia. It increases the risk of erectile dysfunction and decreased sexual desire.
Strength: 0.5mg
Standard: In-house -
Product Etoposide capsules
Etoposide or VP-16 is a cytotoxic anticancer drug which belongs to thetopoisomerase inhibitor drug class. It is used as a form of chemotherapy for cancers such as Kaposi’s sarcoma, Ewing's sarcoma, lung cancer, testicular cancer, lymphoma, nonlymphocytic leukemia, and glioblastoma multiforme. It is often g...
Jiangsu Hengrui Medicine Co., Ltd. resources (1)
-
Brochure Hengrui Medicine - Company Details
Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance